{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:10:08Z","timestamp":1792397408032,"version":"4.4.0"},"reference-count":35,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1765,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1529-8019.2010.01369.x","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T23:55:24Z","timestamp":1289001324000},"page":"643-650","source":"Crossref","is-referenced-by-count":32,"title":["Skin manifestations of hormone-secreting tumors"],"prefix":"10.1155","volume":"23","author":[{"given":"Serge A.","family":"Jabbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB1|cit1","first-page":"177","volume-title":"Williams textbook of endocrinology","author":"Melmed","year":"2003"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-4362.2002.01638.x","article-title":"Cutaneous signs of acromegaly","volume":"41","author":"Centurion","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.clindermatol.2006.04.011","article-title":"Skin manifestations in acromegaly","volume":"24","author":"Ben-Shlomo","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128071-200304050-00003","article-title":"Cutaneous manifestations of endocrine disorders: a guide for dermatologists","volume":"4","author":"Jabbour","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clindermatol.2006.04.012","article-title":"Cushing's syndrome","volume":"24","author":"Shibli-Rahhal","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB6|cit6","first-page":"718","volume-title":"Dermatology","author":"Callen","year":"2003"},{"issue":"5","key":"10.1111\/j.1529-8019.2010.01369.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1111\/j.1529-8019.2010.01369.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-200105000-00003","article-title":"The glucagonoma syndrome: a review of its features and discussion of new perspectives","volume":"321","author":"Chastain","year":"2001","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1111\/j.1529-8019.2010.01369.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clindermatol.2004.06.011","article-title":"Life-threatening paraneoplastic cutaneous syndromes","volume":"23","author":"Stone","year":"2005","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2010.01369.x-BIB10|cit10","first-page":"4","article-title":"Etiology and pathogenesis of necrolytic migratory erythema: review of the literature","volume":"6","author":"Tierny","year":"2004","journal-title":"MedGenMed"},{"issue":"4","key":"10.1111\/j.1529-8019.2010.01369.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0190-9622(95)90345-3","article-title":"Necrolytic migratory erythema without glucagonoma in patients with liver disease","volume":"32","author":"Marinkovich","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2010.01369.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9098(199604)61:4<306::AID-JSO15>3.0.CO;2-3","article-title":"Rapid resolution of necrolytic migratory erythema after glucagonoma resection","volume":"61","author":"Smith","year":"1996","journal-title":"J Surg Oncol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clindermatol.2006.04.010","article-title":"Dermatologic aspects of thyroid disease","volume":"24","author":"Burman","year":"2006","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2010.01369.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2003.257","article-title":"Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations","volume":"48","author":"Ai","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2010.01369.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/10507250360731541","article-title":"Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy","volume":"13","author":"Fatourechi","year":"2003","journal-title":"Thyroid"},{"issue":"2","key":"10.1111\/j.1529-8019.2010.01369.x-BIB16|cit16","first-page":"89","article-title":"Vitiligo in autoimmune thyroid disease","volume":"3","author":"Shong","year":"1991","journal-title":"Thyroidology"},{"issue":"2","key":"10.1111\/j.1529-8019.2010.01369.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0889-8529(05)70186-9","article-title":"Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease","volume":"30","author":"Ross","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"10.1111\/j.1529-8019.2010.01369.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1111\/j.1529-8019.2010.01369.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1590\/S0004-27302005000500028","article-title":"Carcinoid syndrome: diagnosis and medical management","volume":"49","author":"Lely","year":"2005","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"10.1111\/j.1529-8019.2010.01369.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.clindermatol.2006.04.005","article-title":"Rare syndromes","volume":"24","author":"Jabbour","year":"2006","journal-title":"Clin Dermatol"},{"issue":"11","key":"10.1111\/j.1529-8019.2010.01369.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Medical progress: carcinoid tumors","volume":"340","author":"Kulke","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.2004.06273.x","article-title":"Cutaneous manifestations of the malignant carcinoid syndrome","volume":"152","author":"Bell","year":"2005","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1111\/j.1529-8019.2010.01369.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1046\/j.1365-2362.2001.00890.x","article-title":"Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy","volume":"31","author":"Sanduleanu","year":"2001","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"10.1111\/j.1529-8019.2010.01369.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00004836-200608000-00003","article-title":"Gastrointestinal carcinoids: the evolution of diagnostic strategies","volume":"40","author":"Modlin","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1111\/j.1529-8019.2010.01369.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2010.01369.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.iac.2004.01.002","article-title":"Urticaria pigmentosa","volume":"24","author":"Brockow","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1111\/j.1529-8019.2010.01369.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0889-8588(05)70295-1","article-title":"Mastocytosis and the skin","volume":"14","author":"Soter","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"10.1111\/j.1529-8019.2010.01369.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"issue":"26","key":"10.1111\/j.1529-8019.2010.01369.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1983","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1111\/j.1529-8019.2010.01369.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1983.tb03994.x","article-title":"Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa","volume":"109","author":"Vella Briffa","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clindermatol.2006.04.004","article-title":"Dermatology of androgen-related disorders","volume":"24","author":"Essah","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01369.x-BIB35|cit35","first-page":"587","volume-title":"Williams textbook of endocrinology","author":"Bulun","year":"2002"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2010.01369.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2010.01369.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:58:13Z","timestamp":1671818293000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2010.01369.x"}},"subtitle":["Hormone-secreting tumors"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2010.01369.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}